Federal Register / Vol. 88, No. 204 / Tuesday, October 24, 2023 / Notices 73019 

www.regulations.gov. Submit comments 

via the Federal eRulemaking portal by 

searching the OMB control number 

3090–0300. Select the link ‘‘Comment 

Now’’ that corresponds with 

‘‘Information Collection 3090–0300, 

Implementation of Information 

Technology Security Requirements’’. 

Follow the instructions provided on the 

screen. Please include your name, 

company name (if any), and 

‘‘Information Collection 3090–0300, 

Implementation of Information 

Technology Security Requirements’’ on 

your attached document. 

Instructions: Please submit comments 

only and cite Information Collection 

3090–0300, Implementation of 

Information Technology Security 

Requirements, in all correspondence 

related to this collection. Comments 

received generally will be posted 

without change to regulations.gov, 

including any personal and/or business 

confidential information provided. To 

confirm receipt of your comment(s), 

please check regulations.gov, 

approximately two-to-three days after 

submission to verify posting. 

FOR FURTHER INFORMATION CONTACT: Mr. 

Stephen Carroll, Procurement Analyst, 

at GSARpolicy@gsa.gov or 817–978– 

0609. 

SUPPLEMENTARY INFORMATION: 

A. Purpose 

General Services Acquisition 

Regulations (GSAR) requires that 

contractors accessing information 

systems that support the operations and 

assets of GSA, another agency, 

contractor, or other source, to comply 

with GSA’s IT security policies 

including GSA IT’s security policies 

outlined in CIO 09–48, IT Security 

Procedural Guide: Security and Privacy 

IT Acquisition Requirements and CIO 

12–2018, IT Policy Requirements Guide. 

B. Annual Reporting Burden 

Respondents: 117. 

Responses per Respondent: 2. 

Total Annual Responses: 234. 

Hours per Response: 5. 

Total Burden Hours: 1,170. 

C. Public Comments 

Public comments are particularly 

invited on: Whether this collection of 

information is necessary for the proper 

performance of functions of the GSAR, 

and whether it will have practical 

utility; whether our estimate of the 

public burden of this collection of 

information is accurate, and based on 

valid assumptions and methodology; 

ways to enhance the quality, utility, and 

clarity of the information to be 

collected; and ways in which we can 

minimize the burden of the collection of 

information on those who are to 

respond, through the use of appropriate 

technological collection techniques or 

other forms of information technology. 

Obtaining Copies of Proposals: 

Requesters may obtain a copy of the 

information collection documents from 

the Regulatory Secretariat Division 

(MVCB), at GSARegSec@gsa.gov. Please 

cite OMB Control No. 3090–0300, 

Implementation of Information 

Technology Security Requirements, in 

all correspondence. 

Jeffrey A. Koses, 

Senior Procurement Executive, Office of 

Acquisition Policy, Office of Governmentwide Policy. 

[FR Doc. 2023–23445 Filed 10–23–23; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Mine Safety and Health Research 

Advisory Committee 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice of meeting. 

SUMMARY: In accordance with regulatory 

provisions, the Centers for Disease 

Control and Prevention (CDC) 

announces the following meeting of the 

Mine Safety and Health Research 

Advisory Committee (MSHRAC). This is 

a hybrid meeting, accessible both in 

person and virtually. It is open to the 

public and limited only by the space 

available and the number of web 

conference lines available. Time will be 

available for public comment. 

DATES: The meeting will be held on 

November 15, 2023, from 8:30 a.m. to 

1:30 p.m., EST. 

ADDRESSES: National Mine Health & 

Safety Academy, 1301 Airport Road, 

Beaver, West Virginia 25813. The 

conference room accommodates 

approximately 49 people. 

Please note that the meeting location 

is a federal facility and in-person access 

is limited to U.S. citizens unless prior 

authorizations, taking up to 30 to 60 

days, have been made. 

If you wish to attend the meeting 

either in person or virtually, please 

contact Ms. Berni Metzger by email at 

Metzger@cdc.gov or by phone at (412) 

386–4541 at least 5 business days in 

advance of the meeting. If you are 

attending virtually, she will provide you 

with the Zoom web conference access 

information (500 web conference lines 

are available). 

FOR FURTHER INFORMATION CONTACT: 

Steven Mischler, Ph.D., Designated 

Federal Officer, Mine Safety and Health 

Research Advisory Committee, National 

Institute for Occupational Safety and 

Health, Centers for Disease Control and 

Prevention, 626 Cochrans Mill Road, 

Pittsburgh, Pennsylvania 15236. 

Telephone: (412) 386–5688; Email: 

SMischler@cdc.gov. 

SUPPLEMENTARY INFORMATION:

Purpose: The Mine Safety and Health 

Research Advisory Committee is 

charged with providing advice to the 

Secretary, Department of Health and 

Human Services; the Director, Centers 

for Disease Control and Prevention; and 

the Director, National Institute for 

Occupational Safety and Health 

(NIOSH), on priorities in mine safety 

and health research, including grants 

and contracts for such research, 30 

U.S.C. 812(b)(2), Section 102(b)(2). 

Matters To Be Considered: The agenda 

will include discussions on NIOSH 

mining safety and health research 

organizational structure, capabilities, 

projects, and outcomes, as well as a 

verbal report from the Mace 

Development Workgroup. The meeting 

will also include an update from the 

NIOSH Associate Deputy Director, Mine 

Safety and Research. Agenda items are 

subject to change as priorities dictate. 

Public Participation 

Written Public Comment: The public 

may submit written comments or 

questions in advance of the meeting, to 

the Designated Federal Officer (see FOR

FURTHER INFORMATION CONTACT above). 

Written comments received in advance 

of the meeting will be included in the 

official record of the meeting, and 

questions will be answered during the 

oral comment period open to public 

participation. 

Oral Public Comment: The meeting 

will include time for members of the 

public to make an oral comment. The 

public comment session will be held on 

November 15, 2023, at 12:50 p.m., EST, 

or the conclusion of the planned 

presentations, whichever comes first. 

Members of the public will be allocated 

5 to 10 minutes each for presentations 

or comments, as a function of the 

number of commenters. 

The Director, Office of Strategic 

Business Initiatives, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 


ddrumheller on DSK120RN23PROD with NOTICES1
73020 Federal Register / Vol. 88, No. 204 / Tuesday, October 24, 2023 / Notices 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Office of Strategic Business 

Initiatives, Office of the Chief Operating 

Officer, Centers for Disease Control and 

Prevention. 

[FR Doc. 2023–23459 Filed 10–23–23; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Notice of Closed Meeting 

Pursuant to 5 U.S.C section 1009(d), 

notice is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended, and the Determination of 

the Director, Office of Strategic Business 

Initiatives, Office of the Chief Operating 

Officer, CDC, pursuant to Public Law 

92–463. The grant applications and the 

discussions could disclose confidential 

trade secrets or commercial property 

such as patentable material, and 

personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Disease, 

Disability, and Injury Prevention and 

Control Special Emphasis Panel (SEP)— 

CE24–034, Rigorous Evaluation of 

Policies for their Impacts on the Primary 

Prevention of Multiple Forms of 

Violence. 

Date: February 27, 2024. 

Time: 8 a.m.–5 p.m., EST. 

Place: Web Conference. 

Agenda: To review and evaluate grant 

applications. 

For Further Information Contact: 

Carlisha Gentles, PharmD, BCPS, 

CDCES, Scientific Review Officer, 

National Center for Injury Prevention 

and Control, CDC, 4770 Buford Highway 

NE, Mailstop F–63, Atlanta, Georgia 

30341, Telephone: (770)488–1504; 

Email: CGentles@cdc.gov. 

The Director, Office of Strategic 

Business Initiatives, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Office of Strategic Business 

Initiatives, Office of the Chief Operating 

Officer, Centers for Disease Control and 

Prevention. 

[FR Doc. 2023–23458 Filed 10–23–23; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Board of Scientific Counselors, Deputy 

Director for Infectious Diseases 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice of meeting. 

SUMMARY: In accordance with regulatory 

provisions, the Centers for Disease 

Control and Prevention (CDC) 

announces the following meeting of the 

Board of Scientific Counselors, Deputy 

Director for Infectious Diseases (BSC, 

DDID). This virtual meeting is open to 

the public via Zoom, limited only by the 

number of web conference lines 

available (500 lines). Registration in 

advance is required by accessing the 

link below in the addresses section. 

Time will be available for public 

comment. 

DATES: The meeting will be held on 

November 30, 2023, from 1:30 p.m. to 3 

p.m., EST. 

ADDRESSES: Zoom virtual meeting. 

Registration in advance is required by 

accessing the link at https://

cdc.zoomgov.com/webinar/register/WN_

_r2EU3xBTB6MBiQq_HdqNQ. 

Instructions to access the meeting will 

be provided following registration. 

FOR FURTHER INFORMATION CONTACT: 

Sarah Wiley, MPH, Senior Advisor, 

National Center for Emerging and 

Zoonotic Infectious Diseases, Centers for 

Disease Control and Prevention, 1600 

Clifton Road NE, Mailstop H16–5, 

Atlanta, Georgia 30329–4037. 

Telephone: (404) 639–4840; Email: 

SWiley@cdc.gov. 

SUPPLEMENTARY INFORMATION: Purpose: 

The Board of Scientific Counselors, 

Deputy Director for Infectious Diseases 

(BSC, DDID) provides advice and 

guidance to the Secretary, Department 

of Health and Human Services; the 

Director, Centers for Disease Control 

and Prevention (CDC); and the Directors 

of the National Center for Emerging and 

Zoonotic Infectious Diseases, the 

National Center for HIV, Viral Hepatitis, 

STD, and TB Prevention, the National 

Center for Immunization and 

Respiratory Diseases, concerning 

strategies, goals, and priorities for the 

programs and research within the 

national centers and monitors the 

overall strategic direction and focus of 

CDC’s infectious disease programs and 

centers. 

Matters To Be Considered: The agenda 

will include updates and discussions on 

recent outbreaks and disease 

surveillance strategies, as well as a brief 

report from one of the Board’s 

workgroups: the Food Safety 

Modernization Act Surveillance 

Working Group. Agenda items are 

subject to change as priorities dictate. 

The Director, Office of Strategic 

Business Initiatives, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Office of Strategic Business 

Initiatives, Office of the Chief Operating 

Officer, Centers for Disease Control and 

Prevention. 

[FR Doc. 2023–23460 Filed 10–23–23; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Notice of Closed Meeting 

Pursuant to section 5 U.S.C. 

Section1009(d), notice is hereby given 

of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended, and the Determination of 

the Director, Office of Strategic Business 

Initiatives, Office of the Chief Operating 

Officer, CDC, pursuant to Public Law 

92–463. The grant applications and the 

discussions could disclose confidential 

trade secrets or commercial property 

such as patentable material, and 

personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 


ddrumheller on DSK120RN23PROD with NOTICES1